The number of parents claiming religious exemptions for vaccines has risen, according to a study. The research suggests that more parents are claiming religious exemptions as some states eliminate the “personal belief” option for vaccine exemptions. (STAT)

Analysts have said the decision to approve Biogen’s Alzheimer’s drug may be “political.” The Food and Drug Administration’s decision on the drug may depend on public and political pressure, said a Jefferies analyst. The agency may face pressure from patients for the drug because there is no approved medicine to treat Alzheimer’s. (CNBC)

A severe shortage of immune globulin has affected epilepsy, cancer and immune treatments. Doctors nationwide are canceling infusions or rationing treatments as the shortage continues. The FDA is urging manufacturers to boost supply. (Washington Post)

A woman’s rare genetic mutation may help develop Alzheimer’s drugs. Researchers found that a woman with a family history of Alzheimer’s did not develop the condition because of two genetic mutations. The study may shift the thinking on what causes Alzheimer’s, leading to more effective drugs. (Reuters)

FDA committee recommended Makena be withdrawn. The drug, made by Amag, is approved to prevent preterm births, but recent evidence suggested that the drug was not effective. Some of the committee suggested withdrawing the drug completely, while others wanted to leave it on the market and pursue more research. (CNN)